Table 1: Patients characteristics examined in the study.

RA no. 35
Value (  ± SD)
Control healthy group no. 35
Value (  ± SD)

Male/female relation8/2718/17
Middle average age (years)55.57 (±5.68)
(39–65)
45.10 (±11.37)
(29–65)
Middle duration (time) of disease (month)42.86 (±44.12)
(5–157)
0.00 (±0.00)
(0.00-0.00)
Previous therapy with oral corticosteroids
(no. of patients)
00
Previus therapy with methotrexate
(no. of patients)
00